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about 3 months before for an episode of 
acute pancreatitis which resolved rapidly. 
The physical examination revealed that the 
patient was thin, tachypnoic (20 breaths per 
minute), tachycardic, and there were fea-
tures of a right-sided pleural effusion; the 
abdominal examination was unremarkable. 
There was no oedema.
INTRODUCTION
The presence of a pleural effusion enables 
a physician to easily obtain a specimen of a 
body cavity fluid. With a systematic analy-
sis of the pleural fluid, in conjunction with 
the clinical features and ancillary laboratory 
data, a clinician should be able to make ei-
ther a presumptive or definitive diagnosis in 
approximately 90% of cases [1,2]. The dif-
ferential diagnosis of exudate poses difficult 
challenge for clinicians.
CLINICAL CASE
A 42-year-old female patient  presented 
with a progressive dyspnoea, chest pain, 
coughing. She had no fever. She was suffer-
ing from depressive syndrome with alcohol 
abuse for a long time. She was hospitalized 
Why we describe this case
We describe this case to show that the 
differential diagnosis of pleural effusions 
should always be kept in mind and not 
to overlook rare causes, to show the way 
to deal with a diagnostic and therapeutic 
plan of pleural effusions, and to stimulate 
to treat the patient, with equal effective-
ness, with less invasive methods
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Case report
Abstract
Pleural effusion is a clinical manifestation shared by several underlying pathologies. The 
differential diagnosis is based on the clinical history, the physical examination, the analysis of 
the pleural fluid, and the laboratory data (mainly blood tests). There are cases, such as the patient 
described, where TC is not enough, and unusual imaging techniques are required for the study of 
pleural effusion, i.e. magnetic resonance cholangiography, cholangiopancreatography (MRCP) 
and endoscopic retrograde cholangiopancreatography (ERCP). 
This case analyses a 42-year-old female patient who arrived with progressive dyspnoea, chest 
pain, cough, a history of alcohol abuse, and a recent episode of acute pancreatitis. The physical 
examination revealed signs of right-sided pleural effusion. These features, together with 
laboratory data, made it possible to pose the diagnosis of pancreaticopleural fistula, to treat it, 
and to obtain a complete healing in a two-month period. 
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After a week the pleural effusion reformed 
and became greenish. The colour of the liquid, 
that looked like the biliary fluid, the absence 
of fever, the anorexia, and the previous detec-
tion of pancreatic cysts induced research of 
amylase in the pleural fluid. The fluid amylase 
in the pleural fluid was 44,000 U/l.
Afterwards, the patient was treated with 
octreotide, oral pancreatic enzyme supple-
ment, opiates, enteral feeding and imipemen. 
The patient preferred to continue the thora-
centesis instead of pleural talc pleurodesis.
A chest x-ray after two months detected 
only a fibrotic area on the front surface of the 
right pleura (Figure 3). The general condi-
tions of the patient improved progressively. 
She returned to work after two months.
Figure 2. CT abdominal 
scan showing the 
persistence of a residual 
right pleural effusion 
and two pseudocysts in 
the head of pancreas
Chest x-ray (Figure 1) showed a massive 
right pleural effusion.
A thoracentesis was performed and the 
fluid sent for chemical, physic, bacterio-
scopic, cultural, and cytological analyses. The 
blood tests revealed the values reported in 
Table I. Transaminases and bilirubin were 
normal.
1,800 ml of cloudy, dark and brown co-
loured fluid were removed with the thora-
centesis.
The results of the laboratory tests on the 
pleural effusion are shown in Table II.
A CT chest and abdominal scan (Fig-
ure 2) showed the persistence of a residual 
right pleural effusion and two pseudocysts 
in the pancreatic head of 10 and 20 mm 
respectively.
Figure 1. Chest x-ray 
of the patient showing 
a massive right pleural 
effusion. Frontal (A) 
and lateral (B) views
  Parameter Value obtained Reference range
Erythrocyte sedimentation rate (ESR) 29 mm/h (in the first hour) 0-21 mm/h
C-reactive protein 1.46 mg% < 5 mg%
Serum amylase 868 U < 195 U
Lipase 339 U < 60 U
Serum LDH 410 UI/l 350-450 UI/l
Serum Protein 6.58 g/dl 6-8 g/dl
Table I. The blood tests of 
the patient
LDH = Lactic Acid 
Dehydrogenase
Parameter Value obtained
White blood cells 520/µl*
LDH 711 UI/l^
Protein 3.28 g/dl§
Table II. The results 
of laboratory tests 
performed on the pleural 
effusion
LDH = Lactic Acid 
Dehydrogenase
*Counts above 50,000/µl 
are usually found only in 
complicated parapneumonic 
effusions, including empyema 
[3,4]. Exudative effusions 
from bacterial pneumonia, 
acute pancreatitis, and 
lupus pleuritis usually have 
total nucleated cell counts 
above 10,000/µl [3,4]. 
Chronic exudates, typified 
by tuberculous pleurisy 
and malignancy, typically 
have nucleated cell counts 
below 5,000/µl [3,4]
^LDH ratio with plasma 
was 1.73, ratio greater 
than 0.6: the fluid is 
defined as an exudate
§Pleural fluid protein/
serum protein ratio greater 
than 0.5: the fluid is 
defined as an exudate
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 y spleen or liver puncture;
 y vasovagal events;
 y seeding the needle tract with tumour;
 y adverse reactions to the anaesthetic or 
topical antiseptic solutions;
 y retained intrapleural catheter fragments 
[9].
A proper thoracentesis requires first of 
all to obtain the informed consent by the 
patient, which, in turn, requires a thorough 
explanation of the entire procedure.
There are two possible positions, according 
to the patient’s ability to sit upright: if he/she 
is able, the sitting position with his/her arms 
After a week the pleural effusion reformed 
and became greenish. The colour of the liquid, 
that looked like the biliary fluid, the absence 
of fever, the anorexia, and the previous detec-
tion of pancreatic cysts induced research of 
amylase in the pleural fluid. The fluid amylase 
in the pleural fluid was 44,000 U/l.
Afterwards, the patient was treated with 
octreotide, oral pancreatic enzyme supple-
ment, opiates, enteral feeding and imipemen. 
The patient preferred to continue the thora-
centesis instead of pleural talc pleurodesis.
A chest x-ray after two months detected 
only a fibrotic area on the front surface of the 
right pleura (Figure 3). The general condi-
tions of the patient improved progressively. 
She returned to work after two months.
Figure 2. CT abdominal 
scan showing the 
persistence of a residual 
right pleural effusion 
and two pseudocysts in 
the head of pancreas
DISCUSSION
As in our case report, pleural effusion 
generally indicates an underlying disease 
process, that may even be of non-pulmonary 
origin [1].
The differential diagnosis of pleural effu-
sion is difficult, due to the huge variety of 
originating causes (Table III). For this rea-
son, a thoracentesis is indicated.
Thoracentesis
In two circumstances diagnostic thora-
centesis is usually not required: when there 
is a small amount of pleural fluid (< 500 cc 
with an ecographic evaluation) and a clear 
clinical diagnosis (e.g., viral pleurisy), or 
when there is clinically obvious heart failure 
(HF) without atypical features [1]. Atypical 
features that should prompt consideration 
of diagnostic thoracentesis in a patient with 
HF are shown in the box.
Thoracentesis procedure needs to be per-
formed with carefulness, especially in some 
high-risk patients, such as elderly and clini-
cally compromised people.
Some complications may occur in every 
patient, in particular [7]:
 y pain at the puncture site;
 y bleeding;
 y pneumothorax (the most common clini-
cally important complication) [8];
 y empyema;
 y soft tissue infection;
Figure 3. Chest x-ray after two months from the beginning of treatment. In the frontal (A) and 
lateral views (B) the pleural effusion appears resolved; only a fibrotic area on the front surface of the 
right pleura is visible
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resting on a table is preferred; otherwise, the 
lateral recumbent position should be used.
The use of opiates, anxiolytics, or sedatives 
is rarely necessary, and atropine isn’t rou-
tinely administered [10].
The standard selection of the puncture site 
is performed under ultrasound guidance, be-
cause the increased accuracy of this method 
has resulted in the decrease of pneumothorax 
rate from 8.6% to 1.1% if compared to the 
previously used physical examination alone 
[11,12]. In case of complex pleural and lung 
parenchymal disease, the additional support 
Transudative 
pleural 
effusions
 y Congestive heart failure (CHF)
 y Cirrhosis
 y Nephrotic syndrome
 y Superior vena caval obstruction
 y Fontan procedure
 y Urinothorax
 y Peritoneal dialysis
 y Glomerulonephritis
 y Myxoedema
 y Cerebrospinal fluid leak to pleura
 y Hypoalbuminaemia
Exudative 
pleural 
effusions
Neoplastic diseases  y Metastatic disease
 y Mesothelioma
 y Body cavity lymphoma
 y Pyothorax-associated 
lymphoma
Infectious diseases  y Bacterial infections
 y Tuberculosis
 y Fungal infections
 y Parasitic infections
 y Viral infections
Pulmonary embolization
Gastrointestinal 
disease
 y Pancreatic disease
 y Subphrenic abscess
 y Intrahepatic abscess
 y Intrasplenic abscess
 y Esophageal perforation
 y Postabdominal surgery
 y Diaphragmatic hernia
 y Endoscopic variceal sclerosis
 y Postliver transplant
Heart diseases  y Postcoronary artery bypass 
graft (post-CABG) surgery
 y Postcardiac injury 
(Dressler) syndrome
 y Pericardial disease
 y Pulmonary vein stenosis 
postcatheter ablation of 
atrial fibrillation
Obstetric and 
gynaecologic disease
 y Ovarian hyperstimulation 
syndrome
 y Fetal pleural effusion
 y Postpartum pleural effusion
 y Meigs syndrome
 y Endometriosis
Collagen vascular 
diseases
 y Rheumatoid pleuritis
 y Systemic lupus 
erythematosus
 y Drug-induced lupus
 y Immunoblastic 
lymphadenopathy
 y Sjögren syndrome
 y Familial Mediterranean fever
 y Churg-Strauss syndrome
 y Wegener granulomatosis
Drug-induced pleural 
disease
 y Nitrofurantoin
 y Dantrolene
 y Methysergide
 y Ergot drugs
 y Amiodarone
 y Interleukin 2
 y Procarbazine
 y Methotrexate
 y Clozapine
Miscellaneous 
diseases and 
conditions
 y Asbestos exposure
 y Postlung transplant
 y Postbone marrow 
transplant
 y Yellow nail syndrome
 y Sarcoidosis
 y Uraemia
 y Trapped lung
 y Therapeutic radiation 
exposure
 y Drowning
 y Amyloidosis
 y Milk of calcium pleural 
effusion
 y Electrical burnsTable III. Causes of pleural effusion. 
Modified from [5]
Situations possibly requiring diagnostic thoracentesis [6]
 y Unilateral effusion (especially in the left side)
 y Bilateral effusions of disparate sizes
 y Pleurisy
 y Fever
 y Normal cardiac silhouette on chest radiograph
 y Echocardiogram inconsistent with heart failure
 y B-type brain natriuretic peptide (BNP) levels inconsistent with 
heart failure
 y Alveolar-arterial oxygen gradient larger than expected
 y Effusion not resolved after heart failure therapy
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By definition, a transudative effusion oc-
curs when the systemic factors, hydrostatic 
or oncotic pressures, influencing the forma-
tion and reabsorption of pleural fluid are al-
tered such that pleural fluid accumulates. An 
effective method to identify the pathogenesis 
of pleural transudate is the measurement of 
pro-BNP in pleural fluid. Several studies 
have demonstrated that N-terminal pro-
brain natriuretic peptide (NT-proBNP) is 
elevated in the pleural fluid of patients who 
have heart failure and pleural effusion [16].
In contrast, an exudative pleural effusion 
occurs when pleural fluid accumulates due 
to alterations in local factors. The first step 
in the clinical workup of a patient with a 
pleural effusion is to determine if the patient 
has a transudative or an exudative pleural ef-
fusion. If the patient has a transudative effu-
sion, no additional diagnostic studies need to 
be directed towards the pleura. Alternatively, 
if the patient has an exudative pleural effu-
sion, as in this case, additional efforts should 
be made to determine what disease process is 
affecting the pleura. The separation of tran-
sudative from exudative pleural effusions is 
best made by simultaneous measurements 
of the protein and Lactic Acid Dehydroge-
nase (LDH) levels in the pleural fluid and in 
the serum. If one or more of the following 
criteria are met, the patient probably has an 
exudative pleural effusion [1]:
 y pleural fluid protein/serum protein > 0.5;
 y pleural fluid LDH/serum LDH > 0.6;
 y absolute pleural fluid LDH > 2/3rds the 
upper limit of normal for serum.
If none of these criteria are met, then 
the patient has a transudative pleural effu-
sion [1,2].
The clinical case described met all 3 cri-
teria indicated above.
No single pleural fluid tumour marker is 
accurate enough for routine use in the di-
agnostic evaluation of pleural effusion [17].
Pancreaticopleural fistula
Pancreaticopleural fistula (PPF) is a rare 
cause of pleural effusion (< 1%) [18]. The 
main cause is represented by acute or chronic 
pancreatitis, due essentially to rupture of 
the pseudocyst or to leakage of pancreatic 
duct with collection of pancreatic juice in 
retroperitoneum. The fistulous tract can 
pass either through the aortic or oesopha-
geal diaphragmatic hiatus [19] or directly 
through erosion of diaphragmatic dome by 
the pseudocyst [19].
of chest-computed tomography may be nec-
essary. However, physical examination is still 
performed for patients with a nonloculated 
free-flowing effusion and when ultrasound 
technique is not available: particular care 
should be taken in avoiding lacerations of 
tortuous intercostal arteries, especially in 
elderly patients [13], and a follow-up after 
thoracentesis is required. 
The sterilization of the skin area surround-
ing the puncture site is generally performed 
by means of 0.05% chlorhexidine or 10% 
povidone-iodine solution: immunocom-
promised patients or those with severe pre-
existing pleural injury are at higher risk if the 
sterilization is performed in the wrong way.
Anaesthetisation is performed by placing 
lidocaine 1% or 2% in the epidermidis with a 
syringe with a 22-gauge needle. Intermittent 
injection of lidocaine is needed to anesthe-
tise also the deeper tissues, rib periosteum 
and parietal pleura [14].
Finally, a 50 ml syringe with a 16 or 
14-gauge needle is used to withdraw the 
pleural fluid; the addition of 1 ml of 1:1000 
heparine is suggested in order to prevent clot-
ting of haemorrhagic or highly proteinaceous 
fluid (it improves also the quality of the cyto-
logic examination of the pleural fluid).
About 30-75 ml of pleural fluid are with-
drawn for analytic purposes.
In the majority of patients, asymptomatic 
and non-ventilated, a chest radiograph after 
thoracentesis is not required [15]. As in our 
case, large volume thoracentesis is required. 
Large volume thoracentesis refers to the re-
moval of more than one litre of pleural fluid 
during a therapeutic thoracentesis. Large 
volume thoracentesis is performed to relieve 
dyspnoea associated with a pleural effusion. 
Assessment of the initial pleural fluid pres-
sure and the changes in pressure as fluid is 
removed (known as the pleural space elas-
tance) can be used to guide fluid removal.
Pleural effusion
The large majority of pleural effusion cases 
are due to congestive heart failure, pneumo-
nia, malignancy, or pulmonary embolism.
After the formation of the effusion, the 
flattening or inversion of the diaphragm oc-
cur, as well as the mechanical dissociation of 
the visceral and parietal pleura and a restric-
tive ventilator defect [2].
Pleural effusions are classified into:
 y transudate pleural effusions; and
 y exudate pleural effusions.
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netic resonance cholangiopancreatography 
(MRCP), endoscopic retrograde cholan-
giopancreatography (ERCP) and CT scan, 
with success rates of 80%, 78% and 47% 
respectively [20].
PPF is a difficult-to-treat condition, due 
to the complexity of anatomical alterations.
There are three options for the treatment 
of PPF:
1. conservative and medical treatment, 
based on repeated thoracentesis and ad-
ministration of octreotide;
2. endoscopic treatment by ERCP with 
sphincterotomy and/or stent placement;
3. surgical treatment in patients unrespon-
sive to previous treatments.
Conservative treatment represents the first 
choice in PPF when there is no evidence of 
stenosis of pancreatic duct; ERCP is useful 
in case of stenosis of pancreatic duct [24]; 
surgical approach is mandatory in case 
of failure of endoscopic treatment and its 
main aim is to avoid septic complications, 
in particular intra-abdominal abscess or 
pleural empyema. That’s why before starting 
treatment of PPF an imaging exam must 
be performed in order to study pancreatic 
anatomy [5].
Although MRCP can be considered the 
gold standard for not invasive diagnosis of 
PPF, in the case described it was not per-
formed for unavailability of the tool in our 
hospital [11]. That’s why CT was performed: 
it didn’t show injuries of pancreatic duct, but 
two pseudocysts alone. The peculiarity of this 
case relies on the female gender of the pa-
tient and on the localization of the effusion 
(on the right side of the thorax).
PPF is difficult to diagnose; it has to 
be ever suspected in presence of recurrent 
pleural effusion in patients with history of 
pancreatitis.
PPF is generally diagnosed in middle-
aged men with history of alcoholism and 
chronic pancreatitis [20]. The effusion is 
generally on the left side of the thorax 
(76%) [21]. Main symptoms are dyspnoea, 
cough, chest pain, fever, and septicaemia. 
The effusion is typically recurrent, in first 
instance, not responsive to thoracentesis. The 
main complications are low grade infection, 
weight loss, and failure to thrive.
Diagnosis is often delayed (range from 
12 to 49 days) [21]. It’s postulated on the 
basis of biochemical analysis of pleural fluid 
(elevated values of amylase and albumin > 
3 g/dl). The diagnosis of PPF pleural fluid 
amylase levels should be greater than se-
rum levels and typically exceed 1,000 IU/l 
[22,23] (see box).
Instrumental techniques provide impor-
tant data. CT scan of thorax represents the 
gold standard for detection of pleural ef-
fusion, but, in order to identify anatomical 
alterations of pancreas and for detection 
of fistulous tract, the better tools are mag-
Differential diagnoses for amylases-rich pleural effusion [9]
 y Acute pancreatitis
 y Cancer
 y Lung
 y Rectum
 y Breast
 y Female reproductive system
 y Metastatic carcinoma
 y Pneumonia
 y Oesophageal perforation
 y Lymphoma
 y Leukaemia
 y Liver cirrhosis
 y Hydronephrosis
 y Pulmonary tuberculosis
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